Alkermes ALKS
NASDAQ ALKS
$45.40 -0.09 (-0.20%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alkermes (ALKS) Net Cash Flow (2010 - 2026)

Alkermes' (ALKS) quarterly Net Cash Flow came in at $160.0 million in Q2 2026, up 31.78% year-over-year from $121.4 million in Q2 2025, and up 120.82% quarter-over-quarter from -$768.2 million in Q1 2026.

Analysis

Alkermes (ALKS) Net Cash Flow (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Net Cash Flow for 17 consecutive years, with $160.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Cash Flow rose 31.78% year-over-year to $160.0 million in Q2 2026; TTM through Jun 2026 was -$9.7 million, a 30.69% increase from a year earlier, with the FY2025 full-year figure at $828.6 million, up 598.21% from the prior year.
  • Net Cash Flow was $160.0 million for Q2 2026 at Alkermes, up from -$768.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $503.3 million in Q4 2025 and troughed at -$768.2 million in Q1 2026.
  • A 5-year average of $9.7 million and a median of $18.9 million in 2022 frame the typical range for Net Cash Flow.
  • Across the five-year window, Net Cash Flow jumped 1333.9% in 2023 and sank 807.0% in 2026, its largest moves.
  • Over 5 years, Net Cash Flow stood at $28.5 million in 2022, then sank by 767.14% to -$190.2 million in 2023, then surged by 44.73% to -$105.1 million in 2024, then jumped by 578.69% to $503.3 million in 2025, then sank by 68.22% to $160.0 million in 2026.
  • The last three Net Cash Flow figures came in at $160.0 million (Q2 2026), -$768.2 million (Q1 2026), and $503.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -1.27 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -2.82 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 757.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -722.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 918.27 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 374.50 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 521.33 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 523.50 Mn
10 Alkermes 7.58 Bn 6.92 Bn 397.90 Mn 159.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 159.98 Mn
Mar 31, 2026 -768.22 Mn
Dec 31, 2025 503.33 Mn
Sep 30, 2025 95.25 Mn
Jun 30, 2025 121.39 Mn
Mar 31, 2025 108.66 Mn
Dec 31, 2024 -105.15 Mn
Sep 30, 2024 -138.86 Mn
Jun 30, 2024 114.40 Mn
Mar 31, 2024 -36.72 Mn
Dec 31, 2023 -190.24 Mn
Sep 30, 2023 -18.08 Mn
Jun 30, 2023 344.39 Mn
Mar 31, 2023 28.93 Mn
Dec 31, 2022 28.52 Mn
Sep 30, 2022 9.31 Mn
Jun 30, 2022 -27.91 Mn
Mar 31, 2022 -54.99 Mn
Dec 31, 2021 27.10 Mn
Sep 30, 2021 52.10 Mn